Author
Listed:
- I Wayan Artana Putra
(Fetomaternal Division, Department of Obstetrics and Gynecology, Prof. Dr. I. G. N. G. Ngoerah General Hospital, Indonesia)
- Evert Solomon Pangkahila
(Fetomaternal Division, Department of Obstetrics and Gynecology, Prof. Dr. I. G. N. G. Ngoerah General Hospital, Indonesia)
- I Nyoman Bayu Mahendra
(Onco-Gynecology Division, Department of Obstetrics and Gynecology, Prof. Dr. I. G. N. G. Ngoerah General Hospital, Indonesia)
- Kadek Fajar Marta
(Urogynecology Reconstruction Division, Department of Obstetrics and Gynecology, Prof. Dr. I. G. N. G. Ngoerah General Hospital, Indonesia)
- I Made Darmayasa
(Obstetric and Gynecology Social Division, Department of Obstetrics and Gynecology, Prof. Dr. I. G. N. G. Ngoerah General Hospital, Indonesia)
- Putu Ngurah Aeland Prilaksana Kalimantara
(Department of Obstetrics and Gynecology, Udayana University, Prof. Dr. I. G. N. G. Ngoerah General Hospital, Indonesia)
Abstract
Introduction: Preeclampsia (PE) is a major cause of maternal morbidity and mortality, particularly in low-resource settings. Although Magnesium Sulfate (MgSO4) is the standard treatment for preventing eclampsia, its precise effects on vascular function, especially regarding Endothelin-1 (ET-1) levels, remain unclear. ET-1, a potent vasoconstrictor, is elevated in hypertensive disorders of pregnancy, contributing to endothelial dysfunction in PE. This study aims to investigate the impact of MgSO4 therapy on plasma ET-1 levels in pregnant women diagnosed with severe PE. Method: This observational follow-up study was conducted at RSUP Prof. Dr. I. G. N. G. Ngoerah, Denpasar, starting in October 2022. Participants included pregnant women with severe PE, aged 20–40 weeks of gestation, receiving MgSO4 therapy. Patients with chronic conditions such as diabetes or pre-existing hypertension were excluded. Blood samples were collected before and after MgSO4 administration, and plasma ET-1 levels were measured using enzyme-linked immunosorbent assay (ELISA). Statistical analysis was conducted using the Wilcoxon test, with a significance level set at p
Suggested Citation
I Wayan Artana Putra & Evert Solomon Pangkahila & I Nyoman Bayu Mahendra & Kadek Fajar Marta & I Made Darmayasa & Putu Ngurah Aeland Prilaksana Kalimantara, 2025.
"Differences in Plasma Endothelin-1 Levels Before and After MgSO4 Administration in Pregnant Women with Preeclampsia,"
European Journal of Medical and Health Sciences, European Open Science, vol. 7(1), pages 33-38, January.
Handle:
RePEc:epw:ejmed0:v:7:y:2025:i:1:id:42228
DOI: 10.24018/ejmed.2025.7.1.2228
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:7:y:2025:i:1:id:42228. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.